Welcome to our dedicated page for Celanese Del SEC filings (Ticker: CE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Scanning Celanese’s (CE) latest 10-K can feel like walking through a refinery—dense process charts, commodity pricing models, and pages of environmental risk factors. If you have searched for Celanese insider trading Form 4 transactions or the Celanese quarterly earnings report 10-Q filing, you already know the struggle. Traditional document viewers bury acetic acid cost swings, engineered materials revenue, and sustainability liabilities deep inside footnotes.
Stock Titan ends that complexity. Our AI parses every disclosure the moment it hits EDGAR, turning raw text into clear commentary. From Celanese Form 4 insider transactions real-time alerts that spotlight executive stock moves to a comparative Celanese earnings report filing analysis that shows quarter-over-quarter margin shifts, we surface what matters. Ask any device for understanding Celanese SEC documents with AI and receive a Celanese annual report 10-K simplified summary in seconds—risk factors, segment data, and cash-flow drivers translated into plain language.
Because Celanese’s value hinges on volatile methanol feedstock, joint-venture output, and specialty polymer demand, context is critical. Our coverage explains every 8-K update, with Celanese 8-K material events explained in straightforward terms, and drills into the DEF 14A so Celanese proxy statement executive compensation details are upfront. Whether you need Celanese executive stock transactions Form 4 before a pricing announcement or real-time alerts on plant outages, Stock Titan’s AI-guided workspace delivers complete SEC filings explained simply—updated continuously and ready for decisive action.
Celanese Corporation (CE) reported a large GAAP loss driven by non‑cash impairments. For Q3 2025, net sales were $2,419 million and net loss was $1,353 million as Other (charges) gains, net totaled $1,491 million. Operating loss was $1,275 million. Year‑to‑date, net sales were $7,340 million with a net loss of $1,173 million.
The quarter included a goodwill impairment of about $1.0 billion in Engineered Materials, an additional $98 million linked to the Micromax® held‑for‑sale classification, and a $346 million impairment of certain trade names. Cash from operations rose to $894 million for the nine months, lifting cash to $1,440 million and shareholders’ equity to $3,954 million. The company signed an agreement on October 28, 2025 to divest its Micromax® portfolio to Element Solutions for approximately $500 million in cash, subject to adjustments and approvals. Celanese also announced plans to close its Lanaken, Belgium facility, expecting $70–$90 million of exit and shutdown costs during 2026–2028.
Debt stood at $11,655 million long‑term (net), with March 2025 note issuances of $700 million (2030, 6.500%), €750 million (2031, 5.000%) and $1,100 million (2033, 6.750%), alongside tender offers for €552 million (2026) and $500 million (2027) notes.
Celanese Corporation announced a Regulation FD webcast for investors and analysts on November 7, 2025 at 9:00 a.m. ET to discuss its third quarter 2025 results. CEO Scott A. Richardson will present, with materials available at investors.celanese.com under News & Events.
The company furnished exhibits including prepared remarks and a slide presentation (Exhibits 99.1(a) and 99.1(b)). Non‑US GAAP measures referenced in the remarks are defined and reconciled to the most comparable US GAAP metrics in Exhibit 99.2. These materials are furnished, not filed.
Celanese Corporation (CE) furnished an 8-K announcing it issued a press release reporting financial results for the third quarter of 2025. The press release is provided as Exhibit 99.1.
Non‑US GAAP measures referenced in the release are reconciled to the most comparable US GAAP measures in Exhibit 99.2. The information was furnished under Item 2.02 and is not deemed filed under the Exchange Act.
Celanese Corporation announced it signed a purchase and sale agreement with Element Solutions Inc to divest the Company’s Micromax® portfolio of products. The closing is described as being subject to regulatory approval and other closing conditions.
The Company furnished a press release as Exhibit 99.1 and included forward‑looking statements referencing expected timing, future performance, and deleveraging efforts. The disclosure was furnished under Regulation FD and is not deemed filed for liability purposes.
Celanese Corporation announced its intent to close its acetate tow facility in Lanaken, Belgium to streamline production costs across its global network. The company plans to permanently cease manufacturing operations in the second half of 2026, subject to a consultation process with the facility’s works council and union representatives.
Celanese expects total expenses of $70–90 million, including $55–65 million of non-cash accelerated depreciation of fixed assets and $15–25 million of other shutdown cash costs. The company expects cash outflows related to these actions during fiscal years 2026 through 2028. Employee termination costs will be determined following the consultation and disclosed afterward. Actual charges may vary depending on the consultation outcome.
Timothy Go, a director of Celanese Corporation (CE), reported two open-market purchases of Common Stock on 09/08/2025. The Form 4 shows 500 shares bought at $46.33 and 539 shares bought at $46.175, leaving him with 4,415 total shares beneficially owned after the transactions. The filing was signed by an attorney-in-fact on 09/09/2025.
Mark Christopher Murray, reported as an officer (SVP - Acetyls) of Celanese Corporation (CE), acquired 2,017 shares of Celanese common stock on 08/14/2025 at a reported price of $41.83 per share. Following the transaction the filing reports 17,000 shares beneficially owned in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 08/18/2025. No derivative transactions are reported on this filing.
Celanese Corporation (CE) director Scott McDougald reported a non-derivative purchase of 2,000 shares on 08/14/2025 at a price of $40.8935 per share, increasing his direct beneficial ownership to 20,376 shares. The Form 4 was signed by an attorney-in-fact on 08/18/2025. No derivative transactions or additional remarks were reported.
Insider purchase disclosed: Celanese Corporation director Ganesh Moorthy bought 1,000 shares of CE common stock on 08/14/2025 at a reported price of $40.942 per share, increasing his direct holdings to 6,015 shares. The filing also shows an indirect holding of 3,000 shares held by the Ganesh and Hema Moorthy Revocable Living Trust. The Form 4 was signed by an attorney-in-fact on 08/18/2025.
Edward G. Galante, a director of Celanese Corporation (CE), reported a sale of company common stock on 08/14/2025. The Form 4 shows 2,400 shares were disposed of at a weighted-average price of $41.272 per share, with prices in the range $40.98 to $41.45. After the reported transaction, Mr. Galante beneficially owned 21,377 shares. The filing was signed by an attorney-in-fact on 08/18/2025 and notes the seller can provide exact per-transaction quantities on request.
FAQ
What is the current stock price of Celanese Del (CE)?
What is the market cap of Celanese Del (CE)?
